News
2d
Zacks Investment Research on MSNReasons to Retain DENTSPLY SIRONA Stock in Your Portfolio NowDENTSPLY SIRONA XRAY is well-positioned for growth due to its new digital-implant work flow and continued focus on research ...
Morgan Stanley downgraded Dentsply Sirona (XRA) to Equal Weight from Overweight and slashed its price target to $14 from $21 per share on Tuesday, noting that the dental product maker is facing a ...
As previously reported, Morgan Stanley downgraded Dentsply Sirona (XRAY) to Equal Weight from Overweight with a price target of $14, down from ...
Dentsply Sirona, which last year announced plans to add over 300 jobs in Charlotte, said Thursday that its board of directors approved the relocation of its principal executive offices from York ...
A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call. Dentsply Sirona is the world’s largest diversified manufacturer of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results